Update: AstraZeneca CEO sticking around for earnings season

AstraZeneca photo.

AstraZeneca confirmed  CEO Pascal Soriot will stick around for the company’s earnings report late this month.

Shares of the company have been battered by reports that Soriot will leave the company to take the top post at troubled Israeli pharmaceutical company Teva.

Reuters and other media outlets reported the news. The lack of a firm  by AZ that the CEO will jump ship led to a more than $7 billion loss in the company’s stock market value at one point last week. 

The French pharma executive has receiv ed  decent marks from investors for a restructuring of the company that has included the downsizing of operations in northern Delaware and the loss of a research center that discovered  Seroquel. The blockbuster drug is used in the treatment of severe mental illness. 

The research site was razed despite efforts by the state to keep the site. AstraZeneca went on to sell its adjoining  South Campus near Wilmington to JPMorgan Chase which now operates a technology center.


Research and development was shifted to the Washington, D.C. area,  the home of  AstraZeneca’s Medimmune subsidiary.

Meanwhile, the company moved its world headquarters from London to a campus in the famous university town of Cambridge. 

The Fairfax, DE  site remains the North American commercial headquarters for the British-based company. AZ also has a distribution and packaging center south of Newark.

The company has struggled with drugs like Seroquel and heartburn drug Nexium moving off patent and fetching much lower prices. 

The company recently announced the sale of its Fairfax site to an investment entity with Wilmington-based Delle Donne and Associates managing the area. In return, AZ will lease a portion of the complex. 

Under Soriot, the company sharpened its development focus in areas such as cancer, diabetes and breathing disorders and sold off other products. Investors are currently awaiting results of a major study on a cancer drug. 

Previous articleBusiness licenses: July 16, 2017
Next article250 expected to attend Millennial Summit at Chase Center
Delaware Business Now is a four-year-old, five-day-a-week newsletter and website operated by Bird Street Media LLC. Publisher and Chief Content Officer is Doug Rainey, a 30-year veteran of business journalism in the state of Delaware.  Business Now focuses on breaking business news in Delaware and immediate adjacent areas with apropriate background and perspective. Also offered exclusively in our FREE newsletter is commentary on state and regional issues. Have a complaint, question or even a compliment? Send an email to drainey@delawarebusinessnow.com. For advertising information, click on the About tab at the top of the home page Our business hours are 8 a.m. to 5 p.m., Monday through Friday. Call us at 302.753.0691.